Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Optional

US Department of Health & Human Services: Food and Drug Administration (FDA)

View website    Save

Deadline: Nov 29, 2021

Grant amount: US $200,000 - US $1,000,000

Fields of work: Health Disparities & Social Determinants of Health

Applicant type: Organizations

Funding uses: Research

Location of project: United States

Location of residency: United States


The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance COVID-19 health equity research.

Areas of interest include:

  • Proposals that focus on advancing racial and ethnic minority participation in COVID-19/COVID-19 variant clinical trials and/or contribute to informing the continued evaluation of the safety and efficacy of FDA approved products (therapeutics, diagnostics, and vaccines) or products subject to EUAs/EUA expansion for the treatment, prevention, or diagnosis of COVID-19.
  • Proposals that support the evaluation of outcomes by demographic data including, but not limited to, ethnicity, race, age, disability, and geography.
  • Proposals that support COVID-19 research to understand diverse patient perspectives, preferences, and unmet needs

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Department Of Health & Human Services: Food And Drug Administration (Fda)

This page was last reviewed October 01, 2021 and last updated October 01, 2021